Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | F12 | P00748 | 1/20 | 0.41 |
| ▸ | F7 | P08709 | 1/20 | 0.41 |
| ▸ | F3 | P13726 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL336974 | 0.98 | DGAT1 (0.50) | DGAT1MAPTMEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL6960112 | 0.96 | DGAT1 (0.49) | DGAT1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL13108706 | 0.88 | DGAT1 (0.62) | DGAT1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL11174091 | 0.88 | DGAT1 (0.50) | DGAT1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL13108721 | 0.86 | DGAT1 (0.52) | DGAT1MAPTMEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL3736474 | 0.86 | DGAT1 (0.49) | DGAT1MAPTMEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL17512889 | 0.86 | DGAT1 (0.60) | DGAT1MEN1KMT2AALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL20766398 | 0.86 | DGAT1 (0.60) | DGAT1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL3739816 | 0.85 | LTA4H (0.53) | DGAT1MAPTNPC1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL3739815 | 0.83 | LTA4H (0.52) | DGAT1MAPTNPC1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115710227-A | Preparation method of indenoisoquinoline derivative | 广东工业大学 | 2023-02-24 | — | — | CN | claimed |
| CN-114295741-A | Method for simultaneously quantifying travoprost and travoprost acid contained in solution sample | 沈阳兴齐眼药股份有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-113912519-B | Crystal form B of 2-cyano-3-amino-3-ethyl phenylacrylate, preparation method and application | 江苏省农药研究所股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-113402424-A | Synthetic method of cyanoacrylate compound | 上海泰初化工技术有限公司 | 2021-09-17 | — | — | CN | claimed |
| EP-4737470-A2 | C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF | Zikani Therapeutics, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12552825-B2 | C10-alkylene substituted 13-membered macrolides and uses thereof | Zikani Therapeutics , Inc. (US) | 2026-02-17 | — | — | US | disclosed |
| EP-3883647-B1 | C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF | ZIKANI THERAPEUTICS INC (US) | 2026-02-11 | — | — | EP | disclosed |
| US-20260035402-A1 | C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF | ZIKANI THERAPEUTICS INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12404221-B2 | Methods of arene alkenylation | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-09-02 | — | — | US | disclosed |
| US-20250223306-A1 | TEAD INHIBITORS AND METHODS OF USE | SPOROS BIOVENTURES, INC., | 2025-07-10 | — | — | US | disclosed |
| US-20250188072-A1 | COMPOUNDS FOR TREATMENT OF CANCER | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2025-06-12 | — | — | US | disclosed |
| EP-4496789-A1 | TEAD INHIBITORS AND METHODS OF USE | Sporos Biodiscovery, Inc. (US) | 2025-01-29 | — | — | EP | disclosed |
| EP-0810858-A2 | BORONIC ACID AND ESTER INHIBITORS OF THROMBIN | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-12-10 | — | — | EP | disclosed |
| US-5563127-A | USEFUL TO TREAT THROMBOSIS | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-10-08 | — | — | US | disclosed |
| WO-1996020689-A2 | BORONIC ACID AND ESTER INHIBITORS OF THROMBIN | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-07-11 | — | — | WO | disclosed |
| EP-0080053-B1 | 3,5-DIPHENYL-1H-1,2,4-TRIAZOLES WITH CONTRAGESTATIONAL ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREOF AND PROCESS FOR THEIR PREPARATION | GRUPPO LEPETIT S.P.A. (IT) | 1986-03-05 | — | — | EP | disclosed |
| US-4535090-A | ANTIFERTILITY AGENTS; ABORTION | GRUPPO LEPETIT S.P.A. (IT) | 1985-08-13 | — | — | US | disclosed |
| EP-0080053-A1 | 3,5-Diphenyl-1H-1,2,4-triazoles with contragestational activity, pharmaceutical compositions thereof and process for their preparation | GRUPPO LEPETIT S.P.A. (IT) | 1983-06-01 | — | — | EP | disclosed |
| US-4379155-A | 3,5-Disubstituted-1H-1,2,4-triazole derivatives | GRUPPO LEPETIT S.P.A. (IT) | 1983-04-05 | — | — | US | disclosed |
| US-4370336-A | OXYTOCICS | GRUPPO LEPETIT S.P.A. (IT) | 1983-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035402-A1 | C10-ALKYLENE SUBSTITUTED 13-MEMBERED MACROLIDES AND USES THEREOF | MALT1, CCR10, CYP51A1 | DGAT1 903/4885MAPT 4810/4885MEN1 3251/4885 |
| US-12552825-B2 | C10-alkylene substituted 13-membered macrolides and uses thereof | MALT1, NR3C2, MRPL21 | DGAT1 698/4885MAPT 4658/4885MEN1 2487/4885 |
| US-12404221-B2 | Methods of arene alkenylation | CYBB, CBR3, AHR | DGAT1 2474/4885MAPT 4342/4885MEN1 4381/4885 |
| US-20250223306-A1 | TEAD INHIBITORS AND METHODS OF USE | TEAD1, TEAD2, TEAD3 | DGAT1 1063/4885MAPT 2193/4885MEN1 4168/4885 |
| US-20250188072-A1 | COMPOUNDS FOR TREATMENT OF CANCER | KLK3, BRDT, ACP3 | DGAT1 1779/4885MAPT 2614/4885MEN1 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.